Vasodilator phosphostimulated protein (VASP) protects endothelial barrier function during hypoxia

Inflammation

Volumn 35, Issue 2, 2012, Pages 566-573

  Schmit, Marthe A ^a   Mirakaj, Valbona ^a,b   Stangassinger, Manfred ^c   König, Klemens ^b   Köhler, David ^a   Rosenberger, Peter ^a,b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Barrier function; Endothel; Hypoxia; Vasodilator stimulated phosphoprotein

Indexed keywords

EVANS BLUE; FIREFLY LUCIFERASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL BARRIER; EXTRAVASATION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERMEABILITY BARRIER; PLASMID; PROMOTER REGION; PROTECTION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; WILD TYPE;

ACTIN CYTOSKELETON; ANIMALS; ANOXIA; CAPILLARY PERMEABILITY; CELL ADHESION MOLECULES; CELL HYPOXIA; CELL LINE; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC;

ANIMALIA; MUS;

EID: 84863779388     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9347-z     Document Type: Article

References (43)

1. Comerford, K.M., D.W. Lawrence, K. Synnestvedt, B.P. Levi, and S.P. Colgan. 2002. Role of vasodilator-stimulated phosphoprotein in protein kinase A-induced changes in endothelial junctional permeability. FASEB J 16: 583-585.
2. Price, C.J., and N.P. Brindle. 2000. Vasodilator-stimulated phosphoprotein is involved in stress-fiber and membrane ruffle formation in endothelial cells. Arterioscler Thromb Vasc Biol 20: 2051-2056.
3. Rentsendorj, O., T. Mirzapoiazova, D. Adyshev, L.E. Servinsky, T. Renne, A.D. Verin, et al. 2008. Role of vasodilator-stimulated phosphoprotein in cGMP-mediated protection of human pulmonary artery endothelial barrier function. Am J Physiol Lung Cell Mol Physiol 294: L686-L697. (Pubitemid 351520101)
4. Rosenberger, P., J. Khoury, T. Kong, T. Weissmuller, A.M. Robinson, and S.P. Colgan. 2007. Identification of vasodilator-stimulated phosphoprotein (VASP) as an HIF-regulated tissue permeability factor during hypoxia. FASEB J 10: 2613-2621. (Pubitemid 47230689)
5. Schlegel, N., and J. Waschke. 2009. VASP is involved in cAMP-mediated Rac 1 activation in microvascular endothelial cells. Am J Physiol Cell Physiol 296: C453-C462.
6. Schlegel, N., S. Burger, N. Golenhofen, U. Walter, D. Drenckhahn, and J. Waschke. 2008. The role of VASP in regulation of cAMP- and Rac 1-mediated endothelial barrier stabilization. Am J Physiol Cell Physiol 294: C178-C188.
7. Schlegel, N., and J. Waschke. 2009. Impaired integrin-mediated adhesion contributes to reduced barrier properties in VASP-deficient microvascular endothelium. J Cell Physiol 220: 357-366.
8. Eltzschig, H.K., and P. Carmeliet. 2011. Hypoxia and inflammation. N Engl J Med 364: 656-665.
9. Wojciak-Stothard, B., L.Y. Tsang, and S.G. Haworth. 2005. Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 288: L749-L760. (Pubitemid 40404144)
10. Wojciak-Stothard, B., L.Y. Tsang, E. Paleolog, S.M. Hall, and S.G. Haworth. 2006. Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxia-induced neonatal pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 290: L1173-L1182. (Pubitemid 43830862)
11. Kayyali, U.S., C.M. Pennella, C. Trujillo, O. Villa, M. Gaestel, and P.M. Hassoun. 2002. Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2. J Biol Chem 277: 42596-42602. (Pubitemid 35285628)
12. Furman, C., A.L. Sieminski, A.V. Kwiatkowski, D.A. Rubinson, E. Vasile, R.T. Bronson, et al. 2007. Ena/VASP is required for endothelial barrier function in vivo. J Cell Biol 179: 761-775. (Pubitemid 350146260)
13. Eltzschig, H.K., M. Faigle, S. Knapp, J. Karhausen, J. Ibla, P. Rosenberger, et al. 2006. Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood 108: 1602-1610. (Pubitemid 44316128)
14. Yamashita, R., Y. Suzuki, H. Wakaguri, K. Tsuitani, K. Nakai, and S. Sugano. 2006. DBTSS: DataBase of Human Transcription Start Sites, progress report 2007. Large-scale collection and characterization of promoters of human andmouse genes 5′-end SAGE for the analysis of transcriptional start sites. Nucleic Acids Res 34: D86-D89.
15. Hohenstein, B., L. Kasperek, D.J. Kobelt, C. Daniel, S. Gambaryan, T. Renne, et al. 2005. Vasodilator-stimulated phosphoprotein-deficient mice demonstrate increased platelet activation but improved renal endothelial preservation and regeneration in passive nephrotoxic nephritis. J Am Soc Nephrol 16: 986-996. (Pubitemid 41710309)
16. Barone, G.W., P.C. Farley, J.M. Conerly, T.L. Flanagan, and I.L. Kron. 1989. Morphological and functional techniques for assessing endothelial integrity: the use of Evans blue dye, silver stains, and endothelial derived relaxing factor. J Card Surg 4: 140-148.
17. Hu, R.J., and V. Bennett. 1991. In vitro proteolysis of brain spectrin by calpain I inhibits association of spectrin with ankyrin-independent membrane binding site(s). J Biol Chem 266: 18200-18205. (Pubitemid 21908066)
18. Lee, A., J.S. Morrow, and V.M. Fowler. 2001. Caspase remodeling of the spectrin membrane skeleton during lens development and aging. J Biol Chem 276: 20735-20742. (Pubitemid 37411163)
19. Roberts-Lewis, J.M., and R. Siman. 1993. Spectrin proteolysis in the hippocampus: a biochemical marker for neuronal injury and neuroprotection. Ann NY Acad Sci 679: 78-86. (Pubitemid 23202400)
20. Garcia, J.G., A.D. Verin, and K.L. Schaphorst. 1996. Regulation of thrombin-mediated endothelial cell contraction and permeability. Semin Thromb Hemost 22: 309-315. (Pubitemid 26414408)
21. Kolodney, M.S., and R.B. Wysolmerski. 1992. Isometric contraction by fibroblasts and endothelial cells in tissue culture: a quantitative study. J Cell Biol 117: 73-82.
22. Garcia, J.G., A. Siflinger-Birnboim, R. Bizios, P.J. Del Vecchio, J. W. Fenton 2nd, and A.B. Malik. 1986. Thrombin-induced increase in albumin permeability across the endothelium. J Cell Physiol 128: 96-104. (Pubitemid 16099466)
23. Wu, N.Z., and A.L. Baldwin. 1992. Transient venular permeability increase and endothelial gap formation induced by histamine. Am J Physiol 262: H1238-H1247.
24. Bouvry, D., C. Planes, L. Malbert-Colas, V. Escabasse, and C. Clerici. 2006. Hypoxia-induced cytoskeleton disruption in alveolar epithelial cells. Am J Respir Cell Mol Biol 35: 519-527. (Pubitemid 44706424)
25. Bogatcheva, N.V., and A.D. Verin. 2008. The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res 76: 202-207.
26. Kwon, O., C.L. Phillips, and B.A. Molitoris. 2002. Ischemia induces alterations in actin filaments in renal vascular smooth muscle cells. Am J Physiol Renal Physiol 282: F1012-F1019. (Pubitemid 34654466)
27. Molitoris, B.A. 1991. Ischemia-induced loss of epithelial polarity: potential role of the actin cytoskeleton. AmJ Physiol 260: F769-F778.
28. Henes, J.,M.A. Schmit, J.C. Morote-Garcia, V. Mirakaj, D. Kohler, L. Glover, et al. 2009. Inflammation-associated repression of vasodilator- stimulated phosphoprotein (VASP) reduces alveolar-capillary barrier function during acute lung injury. FASEB J 23: 4244-4255.
29. Rius, J., M. Guma, C. Schachtrup, K. Akassoglou, A.S. Zinkernagel, V. Nizet, et al. 2008. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807-811. (Pubitemid 351793778)
30. Bonello, S., C. Zahringer, R.S. BelAiba, T. Djordjevic, J. Hess, C. Michiels, et al. 2007. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol 27: 755-761. (Pubitemid 46606703)
31. Sitkovsky, M., and D. Lukashev. 2005. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 5: 712-721. (Pubitemid 43086172)
32. Sitkovsky, M.V., D. Lukashev, S. Apasov, H. Kojima, M. Koshiba, C. Caldwell, et al. 2004. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 22: 657-682. (Pubitemid 38680437)
33. Cummins, E.P., E. Berra, K.M. Comerford, A. Ginouves, K.T. Fitzgerald, F. Seeballuck, et al. 2006. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci USA 103: 18154-18159. (Pubitemid 44871628)
34. Walmsley, S.R., C. Print, N. Farahi, C. Peyssonnaux, R.S. Johnson, T. Cramer, et al. 2005. Hypoxia-induced neutrophil survival is mediated by HIF-1{alpha}-dependent NF-{kappa}B activity. J Exp Med 201: 105-115. (Pubitemid 40130088)
35. Rius, J., M. Guma, C. Schachtrup, K. Akassoglou, A.S. Zinkernagel, V. Nizet, et al. 2008. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 53(7196): 807-811. (Pubitemid 351793778)
36. Eckle, T., M. Faigle, A. Grenz, S. Laucher, L.F. Thompson, and H.K. Eltzschig. 2008. A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111: 2024-2035. (Pubitemid 351451513)
37. Eltzschig, H.K., P. Abdulla, E. Hoffman, K.E. Hamilton, D. Daniels, C. Schonfeld, et al. 2005. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 202: 1493-1505. (Pubitemid 41746596)
38. Eltzschig, H.K., J.C. Ibla, G.T. Furuta, M.O. Leonard, K.A. Jacobson, K. Enjyoji, et al. 2003. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198: 783-796. (Pubitemid 37087777)
39. Eltzschig, H.K., L.F. Thompson, J. Karhausen, R.J. Cotta, J.C. Ibla, S.C. Robson, et al. 2004. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 104: 3986-3992. (Pubitemid 39620148)
40. Morote-Garcia, J.C., P. Rosenberger, J. Kuhlicke, and H.K. Eltzschig. 2008. HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 111: 5571-5580.
41. Synnestvedt, K., G.T. Furuta, K.M. Comerford, N. Louis, J. Karhausen, H.K. Eltzschig, et al. 2002. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 110: 993-1002.
42. Rosenberger, P., J.M. Schwab, V. Mirakaj, E. Masekowsky, A. Mager, J.C. Morote-Garcia, et al. 2009. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 10: 195-202.
43. Profirovic, J., J. Han, A.V. Andreeva, R.F. Neamu, S. Pavlovic, S.M. Vogel, et al. 2011. Vasodilator-stimulated phosphoprotein deficiency potentiates PAR-1-induced increase in endothelial permeability in mouse lungs. J Cell Physiol 226: 1255-1264.